1 The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Reports of the Surgeon General. Atlanta (GA) 2014.
2 Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH, et al.; GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–906. doi:https://doi.org/10.1016/S0140-6736(17)30819-X.
3 Health UDoHaHSSa. Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC; 1964.
4 Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328(7455):1519. doi:https://doi.org/10.1136/bmj.38142.554479.AE.
5 Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321(7257):323–9. doi:https://doi.org/10.1136/bmj.321.7257.323.
6 Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al.; INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368(9536):647–58. doi:https://doi.org/10.1016/S0140-6736(06)69249-0.
7 Jiang F, Wang J, Zhang R, Chen M, Peng D, Sun X, et al. Effects of active and passive smoking on the development of cardiovascular disease as assessed by a carotid intima-media thickness examination in patients with type 2 diabetes mellitus. Clin Exp Pharmacol Physiol. 2015;42(5):444–50. doi:https://doi.org/10.1111/1440-1681.12379.
8 Lee W, Hwang SH, Choi H, Kim H. The association between smoking or passive smoking and cardiovascular diseases using a Bayesian hierarchical model: based on the 2008-2013 Korea Community Health Survey. Epidemiol Health. 2017;39:e2017026. doi:https://doi.org/10.4178/epih.e2017026.
9 Eddy DM, Peskin B, Shcheprov A, Pawlson G, Shih S, Schaaf D. Effect of smoking cessation advice on cardiovascular disease. Am J Med Qual. 2009;24(3):241–9. doi:https://doi.org/10.1177/1062860609332509.
10 Mallaina P, Lionis C, Rol H, Imperiali R, Burgess A, Nixon M, et al. Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) study. BMC Public Health. 2013;13(1):362. doi:https://doi.org/10.1186/1471-2458-13-362.
11 Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest. 2007;131(2):446–52. doi:https://doi.org/10.1378/chest.06-1587.
12 Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, et al.; CHANCES Consortium. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015;350(apr20 2):h1551. doi:https://doi.org/10.1136/bmj.h1551.
13 Pipe AL. Network meta-analysis demonstrates the safety of pharmacotherapy for smoking cessation in cardiovascular patients. Evid Based Med. 2014;19(5):193. doi:https://doi.org/10.1136/eb-2014-110030.
14 Prochaska JJ, Benowitz NL. Smoking cessation and the cardiovascular patient. Curr Opin Cardiol. 2015;30(5):506–11. doi:https://doi.org/10.1097/HCO.0000000000000204.
15 Wilson PW. Smoking, smoking cessation, and risk of cardiovascular disease. Curr Treat Options Cardiovasc Med. 2006;8(4):276–81. doi:https://doi.org/10.1007/s11936-006-0048-0.
16 Doll R, Peto R. Mortality in relation to smoking: 20 years’ observations on male British doctors. BMJ. 1976;2(6051):1525–36. doi:https://doi.org/10.1136/bmj.2.6051.1525.
17 Cupples LA, D’Agostino RB. The Framingham Study. An Epidemiological Investigation of Cardiovascular Disease. Section 34: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study, 30-year Follow-up. Springfield, VA; 1987.
18 Stallones RA. The association between tobacco smoking and coronary heart disease. Int J Epidemiol. 2015;44(3):735–43. doi:https://doi.org/10.1093/ije/dyv124.
19 Franck C, Filion KB, Eisenberg MJ. Smoking cessation in patients with acute coronary syndrome. Am J Cardiol. 2018;121(9):1105–11. doi:https://doi.org/10.1016/j.amjcard.2018.01.017.
20 Snaterse M, Deckers JW, Lenzen MJ, Jorstad HT, De Bacquer D, Peters RJG, et al.; EUROASPIRE Investigators. Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology. Int J Cardiol. 2018;258:1–6. doi:https://doi.org/10.1016/j.ijcard.2018.01.064.
21 Malhotra J, Borron C, Freedman ND, Abnet CC, van den Brandt PA, White E, et al. Association between Cigar or Pipe Smoking and Cancer Risk in Men: A Pooled Analysis of Five Cohort Studies. Cancer Prev Res (Phila). 2017;10(12):704–9. doi:https://doi.org/10.1158/1940-6207.CAPR-17-0084.
22 McCormack VA, Agudo A, Dahm CC, Overvad K, Olsen A, Tjonneland A, et al. Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2010;127(10):2402–11. doi:https://doi.org/10.1002/ijc.25252.
23 Shaper AG, Wannamethee SG, Walker M. Pipe and cigar smoking and major cardiovascular events, cancer incidence and all-cause mortality in middle-aged British men. Int J Epidemiol. 2003;32(5):802–8. doi:https://doi.org/10.1093/ije/dyg206.
24 Wyss A, Hashibe M, Chuang SC, Lee YC, Zhang ZF, Yu GP, et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol. 2013;178(5):679–90. doi:https://doi.org/10.1093/aje/kwt029.
25 Sun YQ, Chen Y, Langhammer A, Skorpen F, Wu C, Mai XM. Passive smoking in relation to lung cancer incidence and histologic types in Norwegian adults: the HUNT study. Eur Respir J. 2017;50(4):1700824. doi:https://doi.org/10.1183/13993003.00824-2017.
26 Metsios GS, Flouris AD, Angioi M, Koutedakis Y. Passive smoking and the development of cardiovascular disease in children: a systematic review. Cardiol Res Pract. 2010;2011:587650. doi:http://dx.doi.org/10.4061/2011/587650.
27 Taylor BV, Oudit GY, Kalman PG, Liu P. Clinical and pathophysiological effects of active and passive smoking on the cardiovascular system. Can J Cardiol. 1998;14(9):1129–39.
28 Humble C, Croft J, Gerber A, Casper M, Hames CG, Tyroler HA. Passive smoking and 20-year cardiovascular disease mortality among nonsmoking wives, Evans County, Georgia. Am J Public Health. 1990;80(5):599–601. doi:https://doi.org/10.2105/AJPH.80.5.599.
29 Pilz H, Oguogho A, Chehne F, Lupattelli G, Palumbo B, Sinzinger H. Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thromb Res. 2000;99(3):209–21. doi:https://doi.org/10.1016/S0049-3848(00)00249-8.
30 Mol MJ, de Rijke YB, Demacker PN, Stalenhoef AF. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis. 1997;129(2):169–76. doi:https://doi.org/10.1016/S0021-9150(96)06022-4.
31 Noh JM, Lee SH, Kim HW, Yang HS. Changes in the Serum Level of High Density Lipoprotein-cholesterol after Smoking Cessation among Adult Men. Korean J Fam Med. 2012;33(5):305–10. doi:https://doi.org/10.4082/kjfm.2012.33.5.305.
32 Lawlor DA, Song YM, Sung J, Ebrahim S, Smith GD. The association of smoking and cardiovascular disease in a population with low cholesterol levels: a study of 648,346 men from the Korean national health system prospective cohort study. Stroke. 2008;39(3):760–7. doi:https://doi.org/10.1161/STROKEAHA.107.494823.
33 Vazquez-Benitez G, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, et al. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care. 2015;38(5):905–12. doi:https://doi.org/10.2337/dc14-1877.
34 Odeberg J, Freitag M, Forssell H, Vaara I, Persson ML, Odeberg H, et al. The influence of smoking and impaired glucose homoeostasis on the outcome in patients presenting with an acute coronary syndrome: a cross-sectional study. BMJ Open. 2014;4(7):e005077. doi:https://doi.org/10.1136/bmjopen-2014-005077.
35 Gerber PA, Locher R, Schmid B, Spinas GA, Lehmann R. Smoking is associated with impaired long-term glucose metabolism in patients with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2013;23(2):102–8. doi:https://doi.org/10.1016/j.numecd.2011.08.007.
36 Rafalson L, Donahue RP, Dmochowski J, Rejman K, Dorn J, Trevisan M. Cigarette smoking is associated with conversion from normoglycemia to impaired fasting glucose: the Western New York Health Study. Ann Epidemiol. 2009;19(6):365–71. doi:https://doi.org/10.1016/j.annepidem.2009.01.013.
37 Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, et al. The association between smoking and blood pressure in men: a cross-sectional study. BMC Public Health. 2017;17(1):797. doi:https://doi.org/10.1186/s12889-017-4802-x.
38 Jamalizadeh A, Kamiab Z, Esmaeili Nadimi A, Nejadghaderi M, Saeidi A, Porkarami A. Prevalence of smoking and high blood pressure, two major risk factors for non-communicable diseases: the SuRF NCD (surveillance of risk factors of non-communicable disease) report 2012. J Cardiovasc Thorac Res. 2016;8(4):183–7. doi:https://doi.org/10.15171/jcvtr.2016.36.
39 Ohta Y, Kawano Y, Hayashi S, Iwashima Y, Yoshihara F, Nakamura S. Effects of cigarette smoking on ambulatory blood pressure, heart rate, and heart rate variability in treated hypertensive patients. Clin Exp Hypertens. 2016;38(6):510–3. doi:https://doi.org/10.3109/10641963.2016.1148161.
40 Pretorius E, Oberholzer HM, van der Spuy WJ, Meiring JH. Smoking and coagulation: the sticky fibrin phenomenon. Ultrastruct Pathol. 2010;34(4):236–9. doi:https://doi.org/10.3109/01913121003743716.
41 Billimoria JD, Pozner H, Metselaar B, Best FW, James DC. Effect of cigarette smoking on lipids, lipoproteins, blood coagulation, fibrinolysis and cellular components of human blood. Atherosclerosis. 1975;21(1):61–76. doi:https://doi.org/10.1016/0021-9150(75)90094-5.
42 Tibuakuu M, Kamimura D, Kianoush S, DeFilippis AP, Al Rifai M, Reynolds LM, et al. The association between cigarette smoking and inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) study. PLoS One. 2017;12(9):e0184914. doi:https://doi.org/10.1371/journal.pone.0184914.
43 Kianoush S, Yakoob MY, Al-Rifai M, DeFilippis AP, Bittencourt MS, Duncan BB, et al. Associations of Cigarette Smoking With Subclinical Inflammation and Atherosclerosis: ELSA-Brasil (The Brazilian Longitudinal Study of Adult Health). J Am Heart Assoc. 2017;6(6):e005088. doi:https://doi.org/10.1161/JAHA.116.005088.
44 Attard R, Dingli P, Doggen CJM, Cassar K, Farrugia R, Wettinger SB. The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction. Open Heart. 2017;4(2):e000620. doi:https://doi.org/10.1136/openhrt-2017-000620.
45 Sørhaug S, Steinshamn S, Nilsen OG, Waldum HL. Chronic inhalation of carbon monoxide: effects on the respiratory and cardiovascular system at doses corresponding to tobacco smoking. Toxicology. 2006;228(2-3):280–90. doi:https://doi.org/10.1016/j.tox.2006.09.008.
46 Zevin S, Saunders S, Gourlay SG, Jacob P, III, Benowitz NL. Cardiovascular effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol. 2001;38(6):1633–8. doi:https://doi.org/10.1016/S0735-1097(01)01616-3.
47 Kjeldsen K. Smoking and carbon monoxide uptake as a risk factor in atherosclerotic cardiovascular disease. Adv Exp Med Biol. 1975;63:317–21. doi:https://doi.org/10.1007/978-1-4684-3258-9_22.
48 Speeckaert MM, Delanghe JR, Vanholder RC. Chronic nicotine exposure and acute kidney injury: new concepts and experimental evidence. Nephrol Dial Transplant. 2013;28(6):1329–31. doi:https://doi.org/10.1093/ndt/gft019.
49 Kurahashi K, Shirahase H, Nakamura S, Tarumi T, Koshino Y, Wang AM, et al. Nicotine-induced contraction in the rat coronary artery: possible involvement of the endothelium, reactive oxygen species and COX-1 metabolites. J Cardiovasc Pharmacol. 2001;38(Suppl 1):S21–5. doi:https://doi.org/10.1097/00005344-200110001-00006.
50 Chalon S, Moreno H, Jr, Benowitz NL, Hoffman BB, Blaschke TF. Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther. 2000;67(4):391–7. doi:https://doi.org/10.1067/mcp.2000.105153.
51 Mayhan WG, Sharpe GM. Superoxide dismutase restores endothelium-dependent arteriolar dilatation during acute infusion of nicotine. J Appl Physiol (1985). 1998;85(4):1292–8. doi:https://doi.org/10.1152/jappl.1998.85.4.1292.
52 Mayhan WG, Patel KP. Effect of nicotine on endothelium-dependent arteriolar dilatation in vivo. Am J Physiol. 1997;272(5 Pt 2):H2337–42.
53 JH O. Focus on Smoking and Health Research. Hauppauge, NY; 2005.
54 He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease – a meta-analysis of epidemiologic studies. N Engl J Med. 1999;340(12):920–6. doi:https://doi.org/10.1056/NEJM199903253401204.
55 Bonita R, Duncan J, Truelsen T, Jackson RT, Beaglehole R. Passive smoking as well as active smoking increases the risk of acute stroke. Tob Control. 1999;8(2):156–60. doi:https://doi.org/10.1136/tc.8.2.156.
56 Pitsavos C, Panagiotakos DB, Chrysohoou C, Skoumas J, Tzioumis K, Stefanadis C, et al. Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study. Tob Control. 2002;11(3):220–5. doi:https://doi.org/10.1136/tc.11.3.220.
57 Iversen B, Jacobsen BK, Løchen ML. Active and passive smoking and the risk of myocardial infarction in 24,968 men and women during 11 year of follow-up: the Tromsø Study. Eur J Epidemiol. 2013;28(8):659–67. doi:https://doi.org/10.1007/s10654-013-9785-z.
58 Shiue I. Effect of smoking ban at home on adult cardiovascular health: Scottish Health Survey, 2012. Int J Cardiol. 2014;176(1):268–9. doi:https://doi.org/10.1016/j.ijcard.2014.06.097.
59 Sipilä JO, Gunn JM, Kauko T, Rautava P, Kytö V. Association of restaurant smoking ban and the incidence of acute myocardial infarction in Finland. BMJ Open. 2016;6(1):e009320. doi:https://doi.org/10.1136/bmjopen-2015-009320.
60 Di Valentino M, Muzzarelli S, Limoni C, Porretta AP, Rigoli A, Barazzoni F, et al. Reduction of ST-elevation myocardial infarction in Canton Ticino (Switzerland) after smoking bans in enclosed public places--No Smoke Pub Study. Eur J Public Health. 2015;25(2):195–9. doi:https://doi.org/10.1093/eurpub/cku067.
61 Hurt RD, Weston SA, Ebbert JO, McNallan SM, Croghan IT, Schroeder DR, et al. Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med. 2012;172(21):1635–41. doi:https://doi.org/10.1001/2013.jamainternmed.46.
62 Morito N, Miura SI, Yano M, Hitaka Y, Nishikawa H, Saku K. Association Between a Ban on Smoking in a Hospital and the In-Hospital Onset of Acute Myocardial Infarction. Cardiol Res. 2015;6(3):278–82. doi:https://doi.org/10.14740/cr404e.
63 Sebrié EM, Sandoya E, Bianco E, Hyland A, Cummings KM, Glantz SA. Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke-free policy in Uruguay: experience through 2010. Tob Control. 2014;23(6):471–2. doi:https://doi.org/10.1136/tobaccocontrol-2012-050954.
64 Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35(2):158–76. doi:https://doi.org/10.1016/j.amepre.2008.04.009.
65 Janson C, Künzli N, de Marco R, Chinn S, Jarvis D, Svanes C, et al. Changes in active and passive smoking in the European Community Respiratory Health Survey. Eur Respir J. 2006;27(3):517–24. doi:https://doi.org/10.1183/09031936.06.00106605.
66 Holm M, Schiöler L, Andersson E, Forsberg B, Gislason T, Janson C, et al. Predictors of smoking cessation: A longitudinal study in a large cohort of smokers. Respir Med. 2017;132:164–9. doi:https://doi.org/10.1016/j.rmed.2017.10.013.
67 Kale D, Gilbert HM, Sutton S. Are predictors of making a quit attempt the same as predictors of 3-month abstinence from smoking? Findings from a sample of smokers recruited for a study of computer-tailored smoking cessation advice in primary care. Addiction. 2015;110(10):1653–64. doi:https://doi.org/10.1111/add.12972.
68 Ockene JK, Kuller LH, Svendsen KH, Meilahn E. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health. 1990;80(8):954–8. doi:https://doi.org/10.2105/AJPH.80.8.954.
69 Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290(1):86–97. doi:https://doi.org/10.1001/jama.290.1.86.
70 Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012;345(jul10 2):e4439. doi:https://doi.org/10.1136/bmj.e4439.
71 Perkins KA. Smoking cessation in women. Special considerations. CNS Drugs. 2001;15(5):391–411. doi:https://doi.org/10.2165/00023210-200115050-00005.
72 Luo J, Rossouw J, Margolis KL. Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. JAMA. 2013;310(1):94–6. doi:https://doi.org/10.1001/jama.2013.6871.
73 Rice VH, Heath L, Livingstone-Banks J, Hartmann-Boyce J. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2017;12:CD001188.
74 Lindson-Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2015;(3):CD006936.
75 Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;(5):CD000165.
76 Bala MM, Strzeszynski L, Topor-Madry R. Mass media interventions for smoking cessation in adults. Cochrane Database Syst Rev. 2017;11:CD004704.
77 Taylor GMJ, Dalili MN, Semwal M, Civljak M, Sheikh A, Car J. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2017;9:CD007078.
78 Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.
79 Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–20. doi:https://doi.org/10.1016/S0140-6736(16)30272-0.
80 Grandi SM, Shimony A, Eisenberg MJ. Bupropion for smoking cessation in patients hospitalized with cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Can J Cardiol. 2013;29(12):1704–11. doi:https://doi.org/10.1016/j.cjca.2013.09.014.
81 Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;(5):CD006103.
82 Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Addiction. 2014;109(9):1414–25. doi:https://doi.org/10.1111/add.12633.
83 Hagen G, Wisloff T, Klemp M. Cost-Effectiveness of Varenicline, Bupropion and Nicotine Replacement Therapy for Smoking Cessation. NIPH Systematic Reviews. Oslo, Norway2010.
84 Suissa K, Larivière J, Eisenberg MJ, Eberg M, Gore GC, Grad R, et al. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials. Circ Cardiovasc Qual Outcomes. 2017;10(1):e002458. doi:https://doi.org/10.1161/CIRCOUTCOMES.115.002458.
85 Kittle J, Lopes RD, Huang M, Marquess ML, Wilson MD, Ascher J, et al. Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort. Clin Cardiol. 2017;40(10):899–906. doi:https://doi.org/10.1002/clc.22744.
86 Auer R, Gencer B, Tango R, Nanchen D, Matter CM, Lüscher TF, et al. Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons. BMJ Open. 2016;6(9):e011520. doi:https://doi.org/10.1136/bmjopen-2016-011520.
87 Bonetti PO, Trachsel LD, Kuhn MU, Schulzki T, Erne P, Radovanovic D, et al. Incidence of acute myocardial infarction after implementation of a public smoking ban in Graubünden, Switzerland: two year follow-up. Swiss Med Wkly. 2011;141:w13206.
88 Mackay D, Haw S, Ayres JG, Fischbacher C, Pell JP. Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med. 2010;363(12):1139–45. doi:https://doi.org/10.1056/NEJMoa1002861.
89 Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;(2):CD000165.
90 Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016;9:CD010216.
91 National Academies of Sciences E. Medicine. Public Health Consequences of E-Cigarettes. Stratton K, Kwan LY, Eaton DL, editors. Washington, DC: The National Academies Press; 2018. 774 p.